Tian Yi Zhang
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 Mutation (NCT05282459) | Tian Yi Zhang | 2022-01-12 |
Track Tian Yi Zhang automatically
Every clearance here is in the API, with alerts when new ones post.